Lexicon Pharmaceuticals (LXRX)

• Market cap: $871M
• 1 day: 2.08%
• 5 days: 4.26%
• 1 month: -12.11%
• 3 months: 21.74%
• 6 months: 59.35%
• Year to date: 71.93%
• 1 year: 192.54%
• 5 years: -58.65%
• 10 years: -85.77%
• Sector: Healthcare
• Industry: Biotechnology

About: Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Employees: 81